📣 VC round data is live. Check it out!

COSMAX Valuation Multiples

Discover COSMAX's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Intercos, Kolmar Korea, Amorepacific Group, Olaplex Holdings and more.

COSMAX Overview

About COSMAX

Cosmax Inc is a Korean-based specialized cosmetics research and development and manufacturing company. COSMAX develops and provides cosmetics to more than 600 cosmetics brands around the world. The key product consists of skincare, makeup, mask sheets, oriental medicine, haircare, functional cosmetics, and scents. Its products are also sold in Europe, North America, and Central and South America. The company also has four corporations in Shanghai and Guangzhou, China, Indonesia, and the United States.


Founded

1992

HQ

South Korea

Employees

280

Website

cosmax.com

Financials (LTM)

Revenue: $2B
EBITDA: $194M

EV

$2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

COSMAX Financials

COSMAX reported last 12-month revenue of $2B and EBITDA of $194M.

In the same LTM period, COSMAX generated $296M in gross profit, $194M in EBITDA, and $88M in net income.

Revenue (LTM)


COSMAX P&L

In the most recent fiscal year, COSMAX reported revenue of $2B and EBITDA of $184M.

COSMAX is profitable as of last fiscal year, with gross margin of 17%, EBITDA margin of 11%, and net margin of 5%.

See analyst estimates for COSMAX
LTMLast FY202320242025202620272028
Revenue$2B$2B$1B$1B$2B
Gross Profit$296M$271M$194M$277M$271M
Gross Margin17%17%17%19%17%
EBITDA$194M$184M$116M$167M$184M
EBITDA Margin11%11%10%12%12%
EBIT Margin8%8%7%8%8%
Net Profit$88M$85M$38M$57M$81M
Net Margin5%5%3%4%5%
Net Debt-$388M---

Financial data powered by Morningstar, Inc.

COSMAX Stock Performance

COSMAX has current market cap of $1B, and enterprise value of $2B.

Market Cap Evolution


COSMAX's stock price is $112.49.

COSMAX share price decreased by 2.5% in the last 30 days, and by 40.2% in the last year.

COSMAX has an EPS (earnings per share) of $7.46.

See more trading valuation data for COSMAX
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$1B-1.5%-2.5%-15.6%-40.2%$7.46

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

COSMAX Valuation Multiples

COSMAX trades at 1.0x EV/Revenue multiple, and 8.6x EV/EBITDA.

See NTM and 2027E valuation multiples for COSMAX

EV / Revenue (LTM)


COSMAX Financial Valuation Multiples

As of June 3, 2026, COSMAX has market cap of $1B and EV of $2B.

COSMAX has a P/E ratio of 14.5x.

LTMLast FY202320242025202620272028
EV/Revenue1.0x1.0x1.4x1.2x1.1x
EV/EBITDA8.6x9.1x14.4x10.0x9.1x
EV/EBIT11.9x12.7x21.9x14.4x12.9x
EV/Gross Profit5.7x6.2x8.6x6.0x6.2x
P/E14.5x15.1x33.8x22.5x15.7x
EV/FCFn/m(44.7x)17.9x(26.5x)(23.9x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified COSMAX Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

COSMAX Margins & Growth Rates

COSMAX grew revenue by 12% and EBITDA by 14% in the last fiscal year.

In the most recent fiscal year, COSMAX reported gross margin of 17%, EBITDA margin of 11%, and net margin of 5%.

See estimated margins and future growth rates for COSMAX

COSMAX Margins

Last FY202420252026202720282029
Gross Margin17%19%17%18%
EBITDA Margin11%12%12%12%
EBIT Margin8%8%8%8%
Net Margin5%4%5%5%
FCF Margin(2%)(4%)(4%)3%

COSMAX Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth12%22%11%14%
Gross Profit Growth19%42%(2%)19%
EBITDA Growth14%43%10%14%
EBIT Growth14%52%12%17%
Net Profit Growth10%50%43%14%
FCF Growth(256%)(168%)11%(183%)

Data powered by FactSet, Inc. and Morningstar, Inc.

COSMAX Operational KPIs

COSMAX's revenue per employee in the last FY averaged $5.8M, while opex per employee averaged $0.5M for the same period.

COSMAX's Rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

COSMAX's Rule of X is 47% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for COSMAX
LTMLast FY202320242025202620272028
Rule of 4023%26%---
Bessemer Rule of X41%47%---
Revenue per Employee-$5.8M---
Opex per Employee-$0.5M---
S&M Expenses to Revenue3%4%3%5%4%
G&A Expenses to Revenue-1%1%1%1%
R&D Expenses to Revenue-0%0%0%0%
Opex to Revenue-9%10%11%9%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

COSMAX Competitors

COSMAX competitors include Intercos, Kolmar Korea, Amorepacific Group, Olaplex Holdings, Honasa Consumer, Sarantis Group, Perrigo, Procter & Gamble Health, Jamieson Wellness and SILICON2.

Most COSMAX public comparables operate across Health & Beauty.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Intercos1.2x1.1x7.8x7.6x
Kolmar Korea1.0x1.0x8.2x7.7x
Amorepacific Group0.1x-0.3x-
Olaplex Holdings3.3x3.3x14.9x14.9x
Honasa Consumer5.4x5.2x40.8x52.0x
Sarantis Group1.6x1.6x10.8x10.6x
Perrigo1.1x1.1x6.5x6.9x
Procter & Gamble Health7.0x-20.7x-

This data is available for Pro users. Sign up to see all COSMAX competitors and their valuation data.

Start Free Trial

Acquisitions by COSMAX

COSMAX has acquired 2 companies to date.

Last acquisition by COSMAX was on February 22nd 2026. COSMAX acquired Keminova for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by COSMAX

Keminova
ART Lab
Description
Keminova is an Italian firm that manufactures and distributes skincare products alongside medical devices, focusing on wellness and therapeutic applications.
ART Lab is a direct-to-consumer cosmetics brand leveraging AI for personalized skincare formulations. Operating from its online platform, it analyzes user skin data to create custom products shipped directly to customers. The company focuses on tailored serums, creams, and treatments based on individual profiles derived from quizzes and image uploads processed by machine learning algorithms.
HQ CountryItalySouth Korea
HQ City
-
Seoul
Deal Date22 Feb 202629 Nov 2024
Valuationundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all COSMAX acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by COSMAX

COSMAX has invested in 1 company to date.

Latest investment by COSMAX was on October 12th 2020. COSMAX invested in Melixir in their $1M Seed round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by COSMAX

Melixir
Description
Melixir is a Seoul-based skincare brand producing plant-based products inspired by Korean hanbang herbal traditions. Its lineup includes mugwort calming creams, ginseng serums, and rice bran cleansers formulated for sensitive skin types. Certified B Corp, the company uses 100 percent vegan ingredients, cruelty-free testing, and sustainable packaging to minimize emissions, distributing through Sephora Korea and its online store.
HQ CountryUnited States
HQ City
San Francisco, CA
Deal Date12 Oct 2020
RoundSeed
Raised$1M
InvestorsCOSMAX; Dunamu & Partners
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all COSMAX investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About COSMAX

When was COSMAX founded?COSMAX was founded in 1992.
Where is COSMAX headquartered?COSMAX is headquartered in South Korea.
How many employees does COSMAX have?As of today, COSMAX has over 280 employees.
Is COSMAX publicly listed?Yes, COSMAX is a public company listed on Korea Exchange.
What is the stock symbol of COSMAX?COSMAX trades under 192820 ticker.
When did COSMAX go public?COSMAX went public in 2014.
Who are competitors of COSMAX?COSMAX main competitors include Intercos, Kolmar Korea, Amorepacific Group, Olaplex Holdings, Honasa Consumer, Sarantis Group, Perrigo, Procter & Gamble Health, Jamieson Wellness, SILICON2.
What is the current market cap of COSMAX?COSMAX's current market cap is $1B.
What is the current revenue of COSMAX?COSMAX's last 12 months revenue is $2B.
What is the current revenue growth of COSMAX?COSMAX revenue growth (NTM/LTM) is 12%.
What is the current EV/Revenue multiple of COSMAX?Current revenue multiple of COSMAX is 1.0x.
What is the current EBITDA of COSMAX?COSMAX's last 12 months EBITDA is $194M.
What is COSMAX's EBITDA margin?COSMAX's last 12 months EBITDA margin is 11%.
What is the current EV/EBITDA multiple of COSMAX?Current EBITDA multiple of COSMAX is 8.6x.
What is the current FCF of COSMAX?COSMAX's last 12 months FCF is $3M.
What is COSMAX's FCF margin?COSMAX's last 12 months FCF margin is 0%.
What is the current EV/FCF multiple of COSMAX?Current FCF multiple of COSMAX is 569.0x.
How many companies COSMAX has acquired to date?As of June 2026, COSMAX has acquired 2 companies.
What was the largest acquisition by COSMAX?None of the M&A deals COSMAX has completed have disclosed valuations.
What companies COSMAX acquired?COSMAX acquired Keminova and ART Lab.
In how many companies COSMAX has invested to date?As of June 2026, COSMAX has invested in 1 company.
What was the last COSMAX investment?On 12th October 2020 COSMAX invested in Melixir, participating in a $1M Seed round, alongside Dunamu & Partners.
In what companies COSMAX invested in?COSMAX invested in Melixir.

See public comps similar to COSMAX

Lists including COSMAX

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial